Evolent Health (NYSE:EVH) reported quarterly earnings of $0.04 per share which missed the analyst consensus estimate of $0.34 by 88.24 percent. This is a 77.78 percent decrease over earnings of $0.18 per share from the same period last year. The company reported quarterly sales of $621.40 million which missed the analyst consensus estimate of $627.15 million by 0.92 percent. This is a 21.60 percent increase over sales of $511.01 million the same period last year.